Guillain-Barré Syndrome: ImmunotherapyTopic OverviewGuillain-Barré syndrome is a rare nerve disorder that occurs when the body's own defenses (immune system) attack part of the nervous system. For this reason, you may be treated with immunotherapy, which is designed to alter or combat the abnormal immune response by removing the antibodies that are attacking your body. Two types of immunotherapy may be used to treat Guillain-Barré syndrome:
One of these treatments is often started immediately after you have been diagnosed if you seem to be getting worse. Early treatment may reduce your recovery time. Plasma exchange and IVIG appear to be equally effective when given early in the course of the disease. They also have similar costs. The choice between one or the other treatment may depend on what is available and most practical. Related InformationCredits
ByHealthwise Staff Current as ofOctober 9, 2017
Current as of: October 9, 2017 Author: Healthwise Staff Medical Review: Anne C. Poinier, MD - Internal Medicine & Colin Chalk, MD, CM, FRCPC - Neurology |
Search the
Healthwise Knowledgebase Topic ContentsThis information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content. To learn more about Healthwise, visit Healthwise.org. © 1995-2018 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. |